According to a foreign news agency, the results of the initial lab showed that the vaccine developed by Cyanovik Biotech Limited, the most widely used in the world, does not provide enough antibodies in two doses to neutralize the omecron variant and Boosters will be needed to improve safety.
A statement from a team of researchers from the University of Hong Kong said late Tuesday night The serum does not show enough antibodies to neutralize the omecron type.
The company then released its results on Wednesday, saying that seven out of 20 people were 35
The percentage of people who were given two doses during the study showed sufficient antibodies to neutralize omecron.
This was somewhat improved when a booster shot was added to the mix. Sinoweek laboratory results showed that out of a group of 48 people who received three doses, 45 or 94% had omecron-free. There were enough antibodies to work.
In Japan’s research, the Omicron moves at least four times faster than the Delta variant.
Experts say that if more conclusive studies find Sinopharm to be ineffective against Omekron, then China, which has managed to protect the majority of its people from Covid 19 with closed borders and strict preventive measures, has been given a new lease of life. The biggest danger is from the type.
Nicholas Thomas, an associate professor at City University in Hong Kong, said Chinese authorities have worked hard to keep vaccination rates high across the country, but that the virus’s mutations mean that the effects of those efforts have diminished significantly. He said the two-fold challenge facing China now is how to ensure that its population is re-omecroned and protected from any future changes, as well as when the rest of the world lives with the virus. The flow of goods and people should be arranged at their borders so that they can move forward.
Researchers at the University of Hong Kong have advised people to get a third dose of the vaccine as soon as possible.
